Ophthalmology and Optometry Coding Alert

Reader Question:

Use V Codes for Plaquenil Patients

Question: Which diagnosis code should I use to report visual field tests for patients on Plaquenil? Arizona Subscriber Answer: Plaquenil is the trade name for hydroxy-chloroquine, a medication used to treat rheumatoid arthritis and lupus. It can harm the lens and retina of the eye. Primary-care physicians often refer a patient to an ophthalmologist for monitoring ocular changes. The diagnosis coding depends on whether the patient is now taking Plaquenil. For your primary diagnosis, if the patient has completed his course of treatment of the drug, use V67.51 (Follow-up examination; following completed treatment with high risk medications, not elsewhere classified). If the patient is still being treated with the drug, use V58.69 (Long-term [current] use of other medications).

For your secondary diagnosis, code the reason the patient is on Plaquenil, the underlying condition, most typically lupus (710.0) or rheumatoid arthritis (714.0)  
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more